Humana (NYSE:HUM) Price Target Raised to $300.00 at Bank of America

Key Points

• Bank of America has raised its target price for Humana (NYSE:HUM) from $280.00 to $300.00, indicating a potential upside of 5.92% from the stock's previous close.
• Despite the positive outlook from Bank of America, other analysts have mixed views, with Barclays setting a target price as low as $245.00 and Wells Fargo increasing theirs to $347.00.
• Humana's stock has recently traded down 2.5%, with a current price of $283.24, and has a market cap of approximately $34.07 billion.

Humana (NYSE:HUM - Get Free Report) had its target price increased by stock analysts at Bank of America from $280.00 to $300.00 in a research report issued on Friday,Benzinga reports. The firm presently has a "neutral" rating on the insurance provider's stock. Bank of America's target price would indicate a potential upside of 5.92% from the stock's previous close.

Other equities research analysts have also issued reports about the stock. Barclays decreased their target price on shares of Humana from $315.00 to $245.00 and set an "equal weight" rating for the company in a research note on Friday, October 3rd. Wells Fargo & Company boosted their target price on shares of Humana from $344.00 to $347.00 and gave the company an "overweight" rating in a research note on Tuesday. Evercore ISI began coverage on shares of Humana in a research note on Monday, September 22nd. They set an "in-line" rating and a $295.00 target price for the company. Robert W. Baird decreased their target price on shares of Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a research note on Friday, July 25th. Finally, Wall Street Zen lowered shares of Humana from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. Seven equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $298.00.

Humana Stock Down 2.5%

NYSE HUM traded down $7.36 during mid-day trading on Friday, reaching $283.24. The stock had a trading volume of 865,136 shares, compared to its average volume of 1,779,082. Humana has a 1 year low of $206.87 and a 1 year high of $315.35. The stock has a market cap of $34.07 billion, a PE ratio of 21.74, a price-to-earnings-growth ratio of 1.75 and a beta of 0.42. The company has a fifty day moving average price of $278.79 and a 200 day moving average price of $258.16. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm had revenue of $32.39 billion during the quarter, compared to analysts' expectations of $31.85 billion. During the same quarter in the previous year, the firm earned $6.96 earnings per share. Humana's revenue was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. On average, research analysts expect that Humana will post 16.47 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in HUM. Revolve Wealth Partners LLC bought a new position in shares of Humana during the 4th quarter valued at about $202,000. UMB Bank n.a. boosted its holdings in shares of Humana by 99.5% during the 1st quarter. UMB Bank n.a. now owns 373 shares of the insurance provider's stock valued at $99,000 after purchasing an additional 186 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Humana by 54.9% during the 1st quarter. GAMMA Investing LLC now owns 2,952 shares of the insurance provider's stock valued at $781,000 after purchasing an additional 1,046 shares during the last quarter. SG Americas Securities LLC boosted its holdings in shares of Humana by 570.4% during the 1st quarter. SG Americas Securities LLC now owns 18,958 shares of the insurance provider's stock valued at $5,016,000 after purchasing an additional 16,130 shares during the last quarter. Finally, Handelsbanken Fonder AB boosted its holdings in shares of Humana by 3.4% during the 1st quarter. Handelsbanken Fonder AB now owns 30,005 shares of the insurance provider's stock valued at $7,939,000 after purchasing an additional 978 shares during the last quarter. Institutional investors own 92.38% of the company's stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.